CROSSJECT (FRA:74C) FFO


FRA:74C CROSSJECT FRA:74C
42 GF Score
Price €1.75
GF Value €1.12
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is CROSSJECT FFO?

FFO (Funds from operations) only applies to REITs.

FRA:74C
42GF Score
CROSSJECT FRA:74C
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is CROSSJECT (FRA:74C) Overvalued in 2026?

Based on GuruFocus' analysis, CROSSJECT stock appears to be overvalued. The current stock price of €1.75 is trading 55.9% above its estimated GF Value™ of €1.12. GuruFocus considers CROSSJECT to be Significantly Overvalued.

Key valuation signals for FRA:74C:

  • FFO:
  • GF Value™: €1.12 vs. price of €1.75 (55.9% above fair value)
  • GF Score™: 42/100 with 4 warning signs

No single metric tells the full story. See the FRA:74C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CROSSJECT Business Description

Other Exchanges ALCJ:France74C:Germany
Address 60L avenue du 14 Juillet, Chenôve, FRA, 21300
CROSSJECT manufactures and markets needle-free drug self-injection system.
42GF Score

Get the complete analysis for FRA:74C

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.75
Price
€1.12
GF Value